Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction

Murat S., Cavusoglu Y., Yalvac H. E., Sivrikoz I. A., Kocagil S.

KARDIOLOGIA POLSKA, cilt.80, sa.6, ss.672-678, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 80 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.33963/kp.a2022.0098
  • Dergi Adı: KARDIOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.672-678
  • Anahtar Kelimeler: cardiac amyloidosis, diastolic heart failure, heart failure with preserved ejection fraction, red flags, transthyretin, WILD-TYPE TRANSTHYRETIN, ESC GUIDELINES, ECHOCARDIOGRAPHY, HYPOTENSION, DISEASE, UPDATE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background: Heart failure with preserved ejection fraction (HFpEF) is heterogeneous clinical syndrome. Transthyretin cardiac amyloidosis (CA) is an underdiagnosed cause of HFpEF. Red flags are extremely useful for suspecting CA.